---
title: "EUROPEAN CATALYST FUND — Ownership Dossier"
canonical: https://whiteintel.dev/entity/a11eb67b-a8a8-5e15-bb88-ce52865a7828
json: https://whiteintel.dev/api/public/dossier/a11eb67b-a8a8-5e15-bb88-ce52865a7828
identifier: sec:0001347037
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# EUROPEAN CATALYST FUND

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001347037`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/a11eb67b-a8a8-5e15-bb88-ce52865a7828  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/a11eb67b-a8a8-5e15-bb88-ce52865a7828  

## Ownership & control

### Holdings / subsidiaries

- **NURX PHARMACEUTICALS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/47846fda-76ee-55e8-adb6-f91765bdca94

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **EUROPEAN CATALYST FUND**. Human view: https://whiteintel.dev/entity/a11eb67b-a8a8-5e15-bb88-ce52865a7828 · Structured JSON: https://whiteintel.dev/api/public/dossier/a11eb67b-a8a8-5e15-bb88-ce52865a7828._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._